Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc - Common Stock (NQ: AMED )

84.47 +0.69 (+0.82%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,375,039
Open 84.02
Bid (Size) 74.00 (1)
Ask (Size) 85.10 (8)
Prev. Close 83.78
Today's Range 82.15 - 84.87
52wk Range 82.15 - 98.95
Shares Outstanding 32,631,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With UnitedHealth Stock?
UnitedHealth shares have declined 5.3% over the past week. The company faces a significant legal challenge to its $3.3 billion acquisition of Amedisys. 
Via Benzinga

Performance

YTD
-11.06%
-11.06%
1 Month
-6.31%
-6.31%
3 Month
-12.80%
-12.80%
6 Month
-7.83%
-7.83%
1 Year
-11.54%
-11.54%

More News

Read More
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
Via Benzinga
Justice Department Moves To Block UnitedHealth's Amedisys Takeover: What's Going On?
Via Benzinga
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
From Amedisys, Inc.
Via GlobeNewswire
Is NASDAQ:AMED suited for quality investing?
Via Chartmill
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
Via InvestorPlace
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
Via InvestorPlace
3 Stocks Profiting from America’s Long-Term Care Crisis
Via InvestorPlace
What 11 Analyst Ratings Have To Say About Amedisys
Via Benzinga
Analyst Ratings for Amedisys
Via Benzinga
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
Via Benzinga
The 3 Best Stock Picks for This Week
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Is UnitedHealth Group Stock a Buy Now?
Via The Motley Fool
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.